{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:06:57Z","timestamp":1791824817508,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.clinthera.2013.12.005","type":"journal-article","created":{"date-parts":[[2014,1,11]],"date-time":"2014-01-11T00:02:42Z","timestamp":1389398562000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["The Australian Experience With the Human Papillomavirus Vaccine"],"prefix":"10.1016","volume":"36","author":[{"given":"Suzanne M.","family":"Garland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.12.005_bib1","unstructured":"Australian Bureau of Statistics. Population by age, sex, Australian states and territories. www.abs.gov.au\/ausstats\/abs@.nsf\/mf\/3201.0. Accessed November 1, 2013."},{"key":"10.1016\/j.clinthera.2013.12.005_bib2","unstructured":"Department of Health. NHMRC screening to prevent cervical cancer: guidelines for the management of asymptomatic women with screen detected abnormalities. November 2012. www.nhmrc.gov.au\/publications. Accessed November 2, 2013."},{"key":"10.1016\/j.clinthera.2013.12.005_bib3","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clinthera.2013.12.005_bib4","unstructured":"Department of Health and Ageing. Screening: National Cervical Screening Program Renewal. September 2013. www.cancerscreening.gov.au\/internet\/screening\/publishing. Accessed November 2, 2013."},{"key":"10.1016\/j.clinthera.2013.12.005_bib5","unstructured":"Australian Institute of Health and Welfare. Cervical screening in Australia 2008\u20132009. Cancer Series No. 61. Cat. no. CAN 57 2011. www.aihw.gov.au. Accessed December 9, 2013."},{"key":"10.1016\/j.clinthera.2013.12.005_bib6","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2013.12.005_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1741-7015-11-227","article-title":"Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study","volume":"11","author":"Gertig","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.clinthera.2013.12.005_bib8","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.12.005_bib9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.12.005_bib10","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ypmed.2011.08.015","article-title":"Adolescent and young adult HPV vaccination in Australia: achievements and challenges","volume":"53","author":"Garland","year":"2011","journal-title":"Prev Med"},{"key":"10.1016\/j.clinthera.2013.12.005_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.33321\/cdi.2010.34.25","article-title":"Immunisation coverage annual report, 2008","volume":"34","author":"Hull","year":"2010","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.clinthera.2013.12.005_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1071\/SH10001","article-title":"Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia","volume":"8","author":"Gertig","year":"2011","journal-title":"Sex Health"},{"key":"10.1016\/j.clinthera.2013.12.005_bib13","unstructured":"Australian Government Department of Health and Ageing. Immunise Australia program: human papillomavirus (HPV) vaccination program. February 2013. www.immunise.health.gov.au\/. Accessed November 2, 2013."},{"key":"10.1016\/j.clinthera.2013.12.005_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.33321\/cdi.2011.35.18","article-title":"Catching up with the catch-up: interim HPV coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register","volume":"35","author":"Brotherton","year":"2011","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.clinthera.2013.12.005_bib15","first-page":"72","article-title":"HPV vaccination catch up program\u2014utilisation by young Australian women","volume":"38","author":"Weisberg","year":"2009","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.clinthera.2013.12.005_bib16","article-title":"Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey","author":"Brotherton","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2013.12.005_bib17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.5694\/mja13.10272","article-title":"Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach","volume":"199","author":"Brotherton","year":"2013","journal-title":"Med J Aust"},{"key":"10.1016\/j.clinthera.2013.12.005_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5694\/j.1326-5377.2011.tb04138.x","article-title":"Syncope and seizures following human papillomavirus vaccination: a retrospective case series","volume":"194","author":"Crawford","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.clinthera.2013.12.005_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5694\/j.1326-5377.2008.tb02018.x","article-title":"Mass psychogenic response to human papillomavirus vaccination","volume":"189","author":"Buttery","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.clinthera.2013.12.005_bib20","doi-asserted-by":"crossref","first-page":"f5906","DOI":"10.1136\/bmj.f5906","article-title":"Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study","volume":"347","author":"Arnheim-Dahlstr\u00f6m","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2013.12.005_bib21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2013.12.005_bib22","first-page":"607","article-title":"Quadrivalent human papillomavirus vaccine","volume":"45","author":"Barr","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2013.12.005_bib23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/OLQ.0b013e3181971e4e","article-title":"Patterns of treatment of external genital warts in Australian sexual health clinics","volume":"36","author":"Pirotta","year":"2009","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.clinthera.2013.12.005_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/sti.2009.040188","article-title":"Genital warts incidence and healthcare resource utilisation in Australia","volume":"86","author":"Pirotta","year":"2010","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.clinthera.2013.12.005_bib25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/sti.2009.037028","article-title":"The psychosocial burden of human papillomavirus related disease and screening interventions","volume":"85","author":"Pirotta","year":"2009","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.clinthera.2013.12.005_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/sti.2009.037788","article-title":"Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women","volume":"85","author":"Fairley","year":"2009","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.clinthera.2013.12.005_bib27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.clinthera.2013.12.005_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":"Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2013.12.005_bib29","doi-asserted-by":"crossref","first-page":"f2032","DOI":"10.1136\/bmj.f2032","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","volume":"346","author":"Ali","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2013.12.005_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-13-140","article-title":"Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program","volume":"13","author":"Ali","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clinthera.2013.12.005_bib31","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program","volume":"206","author":"Tabrizi","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2013.12.005_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1741-7015-9-104","article-title":"Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program","volume":"9","author":"Garland","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.clinthera.2013.12.005_bib33","unstructured":"Tabrizi SN, Brotherton JM, Kaldor JM, et al. Human papillomavirus prevalence following a national vaccination program. Paper presented at: EUROGIN 2013; November 3\u20136, 2013; Florence, Italy. Abstract No. SS22-1."},{"key":"10.1016\/j.clinthera.2013.12.005_bib34","unstructured":"Australian Government. HPV school vaccination program. February 2013. http:\/\/hpv.health.gov.au. Accessed November 3, 2013."},{"key":"10.1016\/j.clinthera.2013.12.005_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/15513819709168346","article-title":"Juvenile laryngeal papillomatosis in a pediatric population: a clinicopathologic study","volume":"17","author":"Somers","year":"1997","journal-title":"Pediatr Pathol Lab Med"},{"key":"10.1016\/j.clinthera.2013.12.005_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1071\/SH09142","article-title":"Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study","volume":"7","author":"Novakovic","year":"2010","journal-title":"Sex Health"},{"key":"10.1016\/j.clinthera.2013.12.005_bib37","unstructured":"Brotherton JM, Budd A, Gertig D, et al. Impact of HPV vaccination on screening participation. Paper presented at: EUROGIN; November 3\u20136, 2013; Florence, Italy. Abstract No. SS22-4."},{"key":"10.1016\/j.clinthera.2013.12.005_bib38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2407-13-296","article-title":"Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)","volume":"13","author":"Young","year":"2013","journal-title":"BMC Cancer"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181301120X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181301120X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:49:14Z","timestamp":1758962954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929181301120X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S014929181301120X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.12.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Australian Experience With the Human Papillomavirus Vaccine","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier HS Journals, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}